European School of Urology Courses ESU Course 13: Management and outcome in invasive and locally advanced bladder cancer Chair: G.N. Thalmann, Berne (CH)     Aims and objectives: This course will provide urologists with practical information to treat and counsel patients with invasive and locally advanced bladder cancer and focuses on the relevant principles involved in the management of this disease. Major themes covered in this session include treatment options for invasive bladder cancer and proper patient selection, management strategies for invasive and locally advanced disease and the current role of chemotherapy in both the neoadjuvant/adjuvant and metastatic disease settings. The course is very clinically oriented with lectures highlighted by case studies with audience participation. Objectives: After attending this course, the participants should be able to: • Explain the rationale, patient selection and controversies regarding radical surgery for invasive and locally advanced bladder cancer • Understand the rationale and limitations of nonsurgical approaches to the management of invasive and locally advanced bladder cancer • Define the current role and results of neoadjuvant/adjuvant chemotherapy for invasive bladder cancer as well as chemotherapy used in the management of metastatic bladder cancer    Defining the problem - staging, grading, prognosticators of outcome Dr. G.N. Thalmann     Update on neoadjuvant and adjuvant chemotherapy Dr. C.N. Sternberg     Cases - a practical approach Dr. G.N. Thalmann       << Return to previous page    Webcast produced by Prous Science © Prous Science 2010.